Search results for "PLATE"

showing 10 items of 1689 documents

Some remarks on the Caribbean Plate kinematics: facts and remaining problems.

2009

Caribbean Plate Tectonics EvolutionGeologyOcean EngineeringKinematicsSeismologyGeologyWater Science and Technology
researchProduct

Caribbean Plate margin evolution: constraints and current problems

2021

Oceanic crust was generated at multiple spreading centres during the Jurassic and Early Cretaceous, forming a "proto-Caribbean" oceanic domain. During the Cretaceous, part of that crustal domain thickened into an oceanic plateau, of petrologic Mid-Ocean Ridge (MOR) to Ocean Island Basalt (OIB) affinity. Simultaneously, the South and North American continental plates developed rifting and tholeiitic magmatism in the Middle America region (Venezuela and Cuba). The rifting created space for the proto-Caribbean oceanic domain. Petrological and regional correlations suggest that, beginning in the Cretaceous, the proto-Caribbean domain was involved into two main stages of subduction, referred to …

Caribbean PlatePlate-tectonic models.Tectono-magmatic settingCaribbean Plate Ophiolites Tectono-magmatic setting Geodynamic evolution Plate-tectonic models.Caribbean Plate Ophiolites Tectono-magmatic setting Geodynamic evolution Plate-tectonic modelOphiolitesPlate-tectonic modelsGeodynamic evolutionNO
researchProduct

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy

2019

AbstractThe most common causes of ischaemic stroke are represented by carotid artery atherosclerotic disease (CAAD) and atrial fibrillation. While oral anticoagulants substantially reduce the incidence of thromboembolic stroke (< 1%/year), the rate of ischaemic stroke and other cardiovascular disease events in patients with CAAD remains high, ranging from 8.4 to 18.1 events per 100 patient-years. Similar to any other atherosclerotic disease, anti-thrombotic therapies are proposed for CAAD to reduce stroke and other cardiovascular events. The 2017 European Society of Cardiology (ESC)/European Society for Vascular Surgery (ESVS) guidelines recommend for patients with asymptomatic CAAD ≥60%…

Carotid Artery DiseasesMaleRisk0301 basic medicinemedicine.medical_specialtyCardiologyHemorrhageThromboembolic stroke030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRivaroxabanCarotid artery diseaseInternal medicineIschaemic strokeMyocardial RevascularizationmedicineHumansAgedAspirinbusiness.industryIncidence (epidemiology)Atherosclerotic diseaseAnticoagulantsAtrial fibrillationHematologyMiddle AgedAtherosclerosismedicine.diseaseClopidogrelReview articleCarotid Arteries030104 developmental biology[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieCardiovascular Diseasesanti-platelet; anti-thrombotic therapy; anticoagulant; aspirin; carotid artery disease; rivaroxabanCardiologyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusinessPlatelet Aggregation InhibitorsThrombosis and Haemostasis
researchProduct

Tectono-metamorphic history of the Duarte Terrane (Jarabacoa area, Hispaniola Isl.): Insights on the tectonic evolution of the northern rim of the Ca…

2008

Carribean Oceanic Plateau
researchProduct

Dose Responsive Effects of Subcutaneous Pentosan Polysulfate Injection in Mucopolysaccharidosis Type VI Rats and Comparison to Oral Treatment

2014

Background We previously demonstrated the benefits of daily, oral pentosan polysulfate (PPS) treatment in a rat model of mucopolysaccharidosis (MPS) type VI. Herein we compare these effects to once weekly, subcutaneous (s.c.) injection. The bioavailability of injected PPS is greater than oral, suggesting better delivery to difficult tissues such as bone and cartilage. Injected PPS also effectively treats osteoarthritis in animals, and has shown success in osteoarthritis patients. Methodology/principal findings One-month-old MPS VI rats were given once weekly s.c. injections of PPS (1, 2 and 4 mg/kg, human equivalent dose (HED)), or daily oral PPS (4 mg/kg HED) for 6 months. Serum inflammato…

Cartilage ArticularMaleMucopolysaccharidosisMucopolysaccharidosis type VIlcsh:MedicineAdministration OralOsteoarthritisOral administrationMedicine and Health SciencesFemurGrowth Platelcsh:Sciencehealth care economics and organizationsGlycosaminoglycansPentosan Sulfuric PolyesterMucopolysaccharidosis VIMultidisciplinaryMucopolysaccharidosis VIPentosan polysulfateBiomechanical Phenomena3. Good healthFemaleAnatomyResearch Articlemedicine.drugmedicine.medical_specialtyInflammatory DiseasesInjections SubcutaneousMovementeducationUrologyBiological AvailabilityResearch and Analysis MethodsDrug Administration ScheduleAutosomal Recessive DiseasesGeneticsmedicineAnimalsAnimal Models of DiseaseBoneAdverse effectMolecular BiologyClinical GeneticsDose-Response Relationship Drugbusiness.industrylcsh:RTherapeutic effectBiology and Life SciencesMucopolysaccharidosesmedicine.diseaseSpineRatsSurgeryAnimal Studieslcsh:QVeterinary ScienceTomography X-Ray ComputedbusinessPLoS ONE
researchProduct

Morphogenetically active scaffold for osteochondral repair (Polyphosphate/alginate/N,O-carboxymethyl chitosan)

2016

Here we describe a novel bioinspired hydrogel material that can be hardened with calcium ions to yield a scaffold material with viscoelastic properties matching those of cartilage. This material consists of a negatively charged biopolymer triplet, composed of morphogenetically active natural inorganic polyphosphate (polyP), along with the likewise biocompatible natural polymers N,O-carboxymethyl chitosan (N,O-CMC) and alginate. The porosity of the hardened scaffold material obtained after calcium exposure can be adjusted by varying the pre-processing conditions. Various compression tests were applied to determine the local (nanoindentation) and bulk mechanical properties (tensile/compressio…

Cartilage ArticularScaffoldlcsh:Diseases of the musculoskeletal systemO-Carboxymethyl chitosanBiocompatible Materials02 engineering and technology01 natural sciencesHydrogel Polyethylene Glycol DimethacrylateChitosanchemistry.chemical_compoundGlucuronic AcidTissue engineeringPolyphosphatesAggrecansTissue ScaffoldsHexuronic AcidsN021001 nanoscience & nanotechnologymedicine.anatomical_structuretissue engineering0210 nano-technologyPorosityAlginatesEpiphyseal platelcsh:Surgeryregenerative medicineengineering.material010402 general chemistryOsteocytesChondrocytesUltimate tensile strengthmedicineHumansRegenerationCollagen Type IIAggrecanCell ProliferationChitosanWound HealingCartilagepolyphosphatelcsh:RD1-811Alkaline Phosphatase0104 chemical sciencesCartilagechemistryengineeringCalciumBiopolymerlcsh:RC925-935Biomedical engineering
researchProduct

PECAM-1 expression in human mesothelial cells: an in vitro study.

1996

Mesothelial cells are actively involved in inflammatory processes by expressing a set of cell adhesion molecules (CAMs). Transmigration of leukocytes into inflamed tissues requires a chemotactic stimulus and engagement of platelet-endothelial cell adhesion molecule-1 (PECAM-1). To investigate the kinetics involved in peritonitis, pure cultures of mesothelial cells are necessary. In previous studies, we have found that human mesothelial cells (HOMES) show a weak constitutive expression of PECAM-1, which cannot be further stimulated by cytokines. It is known that all serous cavities and body fluids contain numerous macrophages which strongly express this adhesion molecule. To identify the cel…

Cell SeparationIn Vitro TechniquesEpitheliumPathology and Forensic MedicineInterferon-gammaE-selectinmedicineHumansCell adhesionMolecular BiologyCells CulturedbiologyChemistryCell adhesion moleculeTumor Necrosis Factor-alphaMonocyteEpithelial CellsCell BiologyGeneral MedicineCell sortingMolecular biologyImmunohistochemistryRecombinant ProteinsCell biologyPlatelet Endothelial Cell Adhesion Molecule-1Microscopy Electronmedicine.anatomical_structureCell culturebiology.proteinNeural cell adhesion moleculeOmentumMesothelial CellInterleukin-1Pathobiology : journal of immunopathology, molecular and cellular biology
researchProduct

The effects of shock wave stimulation of mesenchymal stem cells on proliferation, migration, and differentiation in an injectable gelatin matrix for …

2020

The treatment of a variety of defects in bony sites could benefit from mitogenic stimulation of osteoprogenitor cells, including endogenous bone marrow-derived mesenchymal stem cells (bMSCs), and from provision of such cells with a matrix permissive of their migration, proliferation, and osteogenic differentiation. That such MSC stimulation could result from treatment with noninvasive (extracorporeal) shock waves (ESWs), and the matrix delivered by injection could enable this therapeutic approach to be employed for applications in which preformed scaffolds and growth factor therapy are difficult to deploy. The objectives of the present study were to investigate focused ESWs for their effect…

Cell Survivalmedicine.medical_treatment0206 medical engineeringBiomedical EngineeringMedicine (miscellaneous)Motility02 engineering and technologyMatrix (biology)InjectionsBiomaterials03 medical and health sciencesCell MovementOsteogenesisIn vivomedicineAnimalsRegenerationCell Proliferation030304 developmental biologyElectroshock0303 health sciencesbiologyChemistryGoatsGrowth factorRegeneration (biology)Mesenchymal stem cellEndoglinCell DifferentiationMesenchymal Stem Cells020601 biomedical engineeringCell biologyCulture Media Conditionedbiology.proteinGelatinPropionatesStem cellBiomarkersPlatelet-derived growth factor receptorJournal of Tissue Engineering and Regenerative Medicine
researchProduct

Cellular physiology of the neonatal rat cerebral cortex.

2003

The early development of the cerebral cortex is characterized by neurogenesis, neuronal migration, cellular differentiation and programmed cell death. Cajal-Retzius cells, developing cortical plate neurons and subplate cells form a transient synaptic circuit which may serve as a template for the formation of cortical layers and columns. These three neuronal cell types show distinct electrophysiological properties and synaptic inputs. Endogenous or exogenous harmful disturbances during this developmental period may lead to the preservation of early cortical circuits, which may act as trigger zones for the initiation of pathophysiological activity.

Cell physiologyCerebral CortexNeuronsCell typeGeneral NeuroscienceCellular differentiationNeurogenesisGlutamate receptorAction PotentialsBiologyCell Physiological PhenomenaRatsElectrophysiologymedicine.anatomical_structureAnimals NewbornCerebral cortexSubplatemedicineAnimalsNeuroscienceBrain research bulletin
researchProduct

Microparticles: Modulators and biomarkers of liver disease

2012

Division of Molecular and Translational Medicine,Dept. of Medicine I, Johannes Gutenberg University, Mainz, GermanyEmerging role of microparticlesMicroparticles (MP) have gained increasing attention as biomark-ers for various diseases. First described as platelet dust, MP wereregarded as unspecific debris [1]. However, it has become appar-ent that cell derived MP or ectosomes represent a novel route ofhorizontal communication between cells. MP are between 100–1000 nm in size and generated through cell membrane shedding(ectocytosis), a process that can be triggered by the activation ofthe complement C5b-9 complex, as shown for platelet derivedMP, or by inhibition of flippase activitythroughCa

Cell signalingCD14+MacrophageT cellCellApoptosisCell CommunicationBiologyMonocyteExosomeAnnexin VCD4+Cell membraneCell-Derived MicroparticlesmedicineHumansMacrophageEctosomeCD41+InflammationHepatologyLiver DiseasesMonocytePlateletNASHT cellBiomarkerDendritic cellCD8+FibrosisHepatitis CCell biologyExosomemedicine.anatomical_structureLiverMicroparticleBiochemistryNAFLiNKTBiomarkersDendritic cellJournal of Hepatology
researchProduct